Lv4
564 积分 2024-02-19 加入
The 6-hydroxydopamine Rat Model of Parkinson's Disease
5个月前
已完结
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
6个月前
已关闭
Animal models of l-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse
6个月前
已完结
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements
6个月前
已完结
Antidepressant properties of rotigotine in experimental models of depression
6个月前
已关闭
The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease
6个月前
已完结
Preparation of Rotigotine-Loaded Microspheres and Their Combination Use with L-DOPA to Modify Dyskinesias in 6-OHDA-Lesioned Rats
6个月前
已完结
Effect of the selective 5-HT2A receptor antagonist EMD-281,014 on l-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned rat
6个月前
已完结
Hypopituitarism
6个月前
已完结
Edaravone dborneol protects against blood-brain barrier disruption following cerebral ischemia/reperfusion by upregulating pericyte coverage via vitronectin-integrin and PDGFB/PDGFR-β signaling
6个月前
已完结
皖公网安备34019202002308
